Greenfield Pathology Services
- Company typePrivate
- Founded2019
- HeadquartersGreenfield, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Greenfield Pathology Services does
Greenfield Pathology Services, Inc. (GPS) is a US-based, privately held professional services firm founded in 2019 by Dr. Ken Schafer in Greenfield, Indiana. The company provides GLP-compliant toxicologic pathology services to pharmaceutical companies, Contract Research Organizations (CROs), and small biotech firms. Its service portfolio spans the full preclinical drug development continuum, from discovery and lead optimization through carcinogenicity assessment, including primary pathology evaluation, peer review, expert consulting, white papers, pathology working groups, and regulatory submission advisory.
The technical foundation is the deep expertise of its 14 board-certified ACVP diplomate pathologists (each averaging more than 20 years of experience), covering subspecialties such as ocular, otic, neuropathology, respiratory system, clinical pathology, and carcinogenicity assessment. The core technical work is microscopic evaluation of tissue samples from preclinical drug safety studies, supported by a Contracts Manager handling client engagement. The firm is founder-led, operates from a single office in Greenfield, Indiana, and discloses no external private equity or venture capital backing, no parent company, no subsidiaries, no partnerships, and no intellectual property filings.
Greenfield Pathology Services firmographics
Firmographics- Name
- Greenfield Pathology Services
- Legal name
- Greenfield Pathology Services, Inc.
- Website
- https://gfpath.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Greenfield Pathology Services industry classification
Industry- Product category
- Toxicologic Pathology Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Pathology & Histopathology Services (HLAGAFAI)
- akta.pro secondary industries
- GLP Toxicology (Repeat-Dose, Acute/Subacute) (HLAGAFAD), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK)
Keywords
Where Greenfield Pathology Services is headquartered
LocationHeadquarters
- HQ city
- Greenfield
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Greenfield Pathology Services business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Professional Pathology Services: Provides toxicologic pathology services including primary evaluation and peer review of toxicology studies, pathology working groups, expert consulting, and regulatory submission support. Services range from slide evaluation to comprehensive pathology reports for drug development programs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Greenfield Pathology Services product offering
Product offeringCore offering
Greenfield Pathology Services provides GLP-compliant toxicologic pathology consulting for nonclinical drug development, delivered by 14 board-certified ACVP diplomate pathologists. The firm offers primary pathology evaluations, peer review of toxicology studies, specialized expertise in ocular/otic/neuropathology and carcinogenicity assessment, pathology working groups, expert consulting, white papers, and regulatory submission advisory support to pharmaceutical and CRO clients.
Product overview
Greenfield Pathology Services provides regulated toxicologic pathology services as a unified service offering. The company offers a comprehensive portfolio of pathology evaluation and peer review services, supported by a team of experienced, board-certified toxicologic pathologists. Services span the full drug development continuum from discovery and lead optimization through carcinogenicity assessment. Core offerings include primary pathology evaluations, peer review, expert consulting, white papers, pathology working groups, and regulatory submission advisory services. Specialized expertise covers ocular, otic, neuropathology, respiratory system, clinical pathology, and carcinogenicity study assessment. The company was founded in 2019 and serves pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs).
Differentiator
Problem solved
Functional benefit
Products and services
- Primary Pathology Evaluation Services Expert toxicologic pathology evaluation conducted by board-certified ACVP diplomates, covering all study types from discovery through regulatory submission, for pharmaceutical, biotech, and CRO clients.
- Pathology Peer Review Services Independent peer review of toxicology study findings by experienced ACVP diplomates to ensure scientific rigor and regulatory compliance for nonclinical studies.
- Expert Consulting and White Papers Professional consulting services and expert-authored white papers on toxicologic pathology matters for regulatory submissions and drug development programs.
- Pathology Working Groups Collaborative pathology working group engagements bringing together multiple expert pathologists from the firm's bench to address complex toxicology questions for clients.
- Regulatory Submission Advisory Guidance and advice on pathology aspects of regulatory submissions to support drug development, approval processes, and interactions with regulatory authorities.
Companies that use Greenfield Pathology Services
Customer profileSegments3 records
Ideal customer profiles3 records
Greenfield Pathology Services technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Greenfield Pathology Services partnerships and signals
Strategic signalScale indicators1 record
Recent moves1 record
Expansion highlights3 records
Greenfield Pathology Services competitors and assessment
Company assessmentEmerging players
- MB Research Laboratories: Preclinical CRO focused on toxicology and safety assessment with related pathology services. Smaller-scale, niche US-based competitor overlapping with GPS' regulatory-grade positioning.
Broad incumbents
- Charles River Laboratories: Global preclinical CRO with large toxicologic pathology group within its Safety Assessment segment. Competes for the same pharma and biotech pathology engagements GPS targets, typically as part of full-service toxicology studies.
- Inotiv: Preclinical CRO offering toxicology, pathology, and research models with integrated toxicologic pathology services. A scaled, multi-modality competitor that bundles pathology into broader preclinical packages.
- Labcorp Drug Development (formerly Covance): One of the largest preclinical CROs globally with in-house toxicologic pathology teams serving global pharma sponsors. Represents both a competitor and a potential partner/subcontractor for overflow pathology work.
- WuXi AppTec: Global CRO/CDMO with preclinical toxicology and pathology capabilities serving both large pharma and small biotech. While China-headquartered, its US operations compete for outsourced pathology work.
- IDEXX BioAnalytics: Provides preclinical and veterinary pathology, including toxicologic pathology support for pharma and device sponsors. Comparable pathology expertise, broader menu of related laboratory services.
Direct peers
- HistoTox Labs: Specialty GLP-compliant histopathology and toxicologic pathology services provider. Closely comparable niche positioning to GPS, focused on regulated preclinical tissue evaluation for drug development.
- EPL Inc. (Experimental Pathology Laboratories): Long-standing US toxicologic and anatomic pathology CRO providing peer review, primary evaluation, and PWG services to pharma and biotech. EPL is the most direct like-for-like competitor to GPS' core toxicologic pathology offering.
- Seventh Wave Laboratories: Mid-sized preclinical CRO offering toxicology, pathology, and bioanalysis services to pharma/biotech. Comparable boutique-to-mid-scale positioning with in-house toxicologic pathology capabilities.
- Vet Path Services (VPS): Veterinary and toxicologic pathology consulting practice serving pharma and chemical industries with peer review, study evaluation, and regulatory pathology support. Closely analogous boutique service model to GPS.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Greenfield Pathology Services social profiles
Digital presenceGreenfield Pathology Services financial estimates
Financial estimateRevenue estimate
Valuation estimate
Greenfield Pathology Services leadership team
Management profileNumber of profiles
Profiles15 records
Greenfield Pathology Services funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Greenfield Pathology Services M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Greenfield Pathology Services
What does Greenfield Pathology Services do?
Greenfield Pathology Services provides GLP-compliant toxicologic pathology consulting for nonclinical drug development, delivered by 14 board-certified ACVP diplomate pathologists. The firm offers primary pathology evaluations, peer review of toxicology studies, specialized expertise in ocular/otic/neuropathology and carcinogenicity assessment, pathology working groups, expert consulting, white papers, and regulatory submission advisory support to pharmaceutical and CRO clients.
Is Greenfield Pathology Services a public or private company?
Greenfield Pathology Services is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Greenfield Pathology Services founded?
Greenfield Pathology Services was founded in 2019. It employs 11 to 50 people.
Where is Greenfield Pathology Services based?
Greenfield Pathology Services is headquartered in Greenfield, United States, in the North America region.
How does Greenfield Pathology Services make money?
One revenue line is on record: professional Pathology Services.
Who are Greenfield Pathology Services's main competitors?
MB Research Laboratories is listed as an emerging player. Broad incumbents are Charles River Laboratories, Inotiv, Labcorp Drug Development (formerly Covance), WuXi AppTec and IDEXX BioAnalytics. Direct peers are HistoTox Labs, EPL Inc. (Experimental Pathology Laboratories), Seventh Wave Laboratories and Vet Path Services (VPS).
Does Greenfield Pathology Services have an API?
No public API is recorded for Greenfield Pathology Services.
What industry is Greenfield Pathology Services in?
Greenfield Pathology Services's product category is Toxicologic Pathology Services. Its primary akta.pro industry code is HLAGAFAI, Pathology & Histopathology Services, with a secondary code of HLAGAFAD, GLP Toxicology (Repeat-Dose, Acute/Subacute). Its NAICS code is 54171 and its SIC code is 8731.